FastCompany36d agobearish
Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get moneyMillions of dollars are available to eligible Chantix buyers, but consumers have until September 14 to submit a claim.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
78last 24h
979last 7d
110● bullish (7d)
126● bearish (7d)
212publishers
Reuters66d agobearish
Celcuity shares fall as delayed breast cancer drug launch eclipses first US FDA approvalJuly 15 () - Shares of Celcuity fell about 8% in premarket trading on Wednesday, as the delayed commercial launch of its newly approved breast cancer drug and treatment-tolerability concerns overshadowed the company's first U. Food and Drug Administration on Tuesday approved gedatolisib, branded as Revtorpyk, for certain patients with advanced breast cancer whose tumors do not carry a PIK3CA mutation.
BioPharma Dive66d agoneutral
Celcuity gains FDA approval for closely-watched breast cancer drugStill, shares fell by nearly 20% after the company revealed a delay in the coming launch of Revtorpyk. Details in the drug’s prescribing information surprised some analysts, too.
Stocktwits66d agoneutral
CELC Stock Clocks Best Day In About 2 Months On First FDA Approval For Cancer DrugGedatolisib, in-licensed from Pfizer in 2021, is Celcuity’s sole late-stage asset.
The Wall Street Journal69d agobearish
New York City Department of Investigation Opens Inquiry Into Buckling Office BuildingSeveral Midtown blocks were shut down earlier this week after structural problems put the high-rise building at risk of partial collapse.
Reuters81d agobearish
Exclusive-US House committee opens investigation into Merck, AbbVie China drug trialsJune 30 (Reuters) - A bipartisan group of U. lawmakers has opened national security investigations into whether drugmakers Merck and AbbVie have been involved in clinical trials conducted in China that helped fuel the communist country's military capability, according to letters seen by Reuters.
MT Newswires86d agobearish
Update: Market Chatter: Pfizer Dismissed From US States' Lawsuit on Generic Drug Price Fixing(Updates with Pfizer's response in the last two paragraphs.) Pfizer (PFE) has been dismissed as a